Annual report pursuant to Section 13 and 15(d)

Molteni Purchase Agreement (Details Textual)

v3.19.1
Molteni Purchase Agreement (Details Textual)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 03, 2018
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 18, 2018
$ / shares
Aug. 03, 2018
EUR (€)
Purchase Agreement [Line Items]                    
Proceeds from Sale of Productive Assets         $ 2,400,000 € 2,000,000        
Revenue Recognition Milestone Methods Description         receive earn-out payments for up to 15 years on net sales of Probuphine in the Molteni Territory ranging in percentage from the low-teens to the mid-twenties. receive earn-out payments for up to 15 years on net sales of Probuphine in the Molteni Territory ranging in percentage from the low-teens to the mid-twenties.        
Debt Instrument, Interest Rate Terms In the event the EMA has not granted marketing approval by December 31, 2019, the Convertible Loan will become due and payable, together with accrued interest at the rate of one-month LIBOR (to the extent in excess of 1.10%) plus 9.50% per annum.                  
Long-term Purchase Commitment, Milestones On August 3, 2018, we entered into an amendment (the “Amendment”) to the Purchase Agreement with Molteni. Under the Amendment, Molteni made an immediate payment to us of €950,000 (approximately $1.1 million) and committed to make a convertible loan to us of €550,000 (approximately $0.6 million) provided we have submitted our response to the 120-day letter from the EMA on or prior to September 14, 2018 in accordance with the Amendment, both in exchange for the elimination of an aggregate of €2.0 million (approximately $2.3 million) of regulatory milestones provided for in the Purchase Agreement that are potentially payable in 2019, at the earliest                  
Estimated Selling Price         $ 1,400,000          
Revenue Recognition Milestone Method Payment     $ 1,100,000 $ 157,000            
Revenue from Contract with Customer, Including Assessed Tax         535,000   $ 0 $ 0    
Amount Received Under Amendment To Purchase Agreement $ 1,100,000                 € 950,000
Convertible Debt $ 600,000                 € 550,000
Share Price | $ / shares                 $ 3.42  
Scenario, Forecast [Member]                    
Purchase Agreement [Line Items]                    
Revenue from Contract with Customer, Including Assessed Tax   $ 104,000                
Intellectual Property [Member]                    
Purchase Agreement [Line Items]                    
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments         $ 1,000,000          
Convertible Debt [Member]                    
Purchase Agreement [Line Items]                    
Debt Instrument, Interest Rate Terms In the event the EMA has not granted marketing approval by December 31, 2019, the Convertible Loan will become due and payable, together with accrued interest at the rate of one-month LIBOR (to the extent in excess of 1.10%) plus 9.50% per annum.